GlassScriptPhysician profile
Christopher Graziano
NPI 1619236973
$12,107.12
in general payments reported to CMS, 2019-2025
31 companies · $2,198 in 2025
The $2,198 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,270 · 2020: $397 · 2021: $595 · 2022: $3,673 · 2023: $1,241 · 2024: $733 · 2025: $2,198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,664 · Travel and Lodging: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,664.49 |
| Travel and Lodging | $507.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,724.36 | 2019-2025 | General - Erectile Dysfunction, Ams 700, Ams 700 Cxr Rte Kit |
| Endo Pharmaceuticals INC. | $3,251.92 | 2019-2024 | Aveed, Xiaflex, Edex |
| Coloplast Corp | $1,163.50 | 2019-2023 | Titan |
| Neotract INC. | $712.76 | 2019 | |
| Endo USA, INC. | $505.63 | 2024-2025 | Xiaflex, Aveed, Edex |
| Astellas Pharma US INC | $253.13 | 2020-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $153.01 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $127.06 | 2022-2024 | Erleada, Akeega |
| Urovant Sciences INC | $124.33 | 2021-2022 | |
| Pfizer INC. | $120.77 | 2023-2025 | |
| Axonics, INC. | $97.34 | 2024 | Axonics |
| Urogen Pharma, INC. | $97.26 | 2023 | Jelmyto |
| Immunitybio, INC. | $90.75 | 2025 | |
| Bioprotect Medical, INC. | $89.32 | 2025 | Bioprotect Balloon Implant System |
| Abbvie INC. | $63.98 | 2021-2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $61.56 | 2023-2025 | Itind System, Tecoflex |
| Ferring Pharmaceuticals INC. | $58.55 | 2025 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $54.84 | 2019-2022 | |
| Blue Earth Diagnostics | $49.14 | 2023-2024 | |
| Progenics Pharmaceuticals, INC. | $43.18 | 2023 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $40.85 | 2021-2025 | |
| Myovant Sciences INC. | $38.33 | 2022 | |
| Tempus Ai, INC | $29.35 | 2024 | Xt Cdx |
| Antares Pharma, INC. | $24.86 | 2021 | |
| Innovation Technologies INC | $24.80 | 2022 | |
| Accord Healthcare, INC. | $21.79 | 2023 | |
| Halozyme INC | $19.43 | 2023 | |
| Azurity Pharmaceuticals, INC. | $18.16 | 2025 | Azmiro |
| Calyxo, INC. | $16.79 | 2025 | Cvac Aspiration System |
| Rigicon,INC. | $16.12 | 2023 | Rigi10 Malleable Penile Prosthesis |
| Merck Sharp & Dohme LLC | $14.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Graziano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.